newsfilter
← Latest News
GlobeNewswire·

Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology

Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune status SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a